Report · 2025
The whole piece is on alkpositive.org.
Open the PDF › on alkpositive.org (opens a new tab)
SIGN UP TODAY
Clinical Trials Update: Can GLP-1’s Tackle Lorlatinib Weight Gain?1 min read · Sep 28
Patient Spotlight: Matt Hiznay4 min read · Sep 28
Baked Honey Glazed Carrots Recipe1 min read · Sep 27
2025 Worldwide ALK TKI Revenues Exceed Three Billion Dollars1 min read · Sep 14
NXP900 + Lorlatinib: Blocking a Potential ALK Bypass Pathway2 min read · Sep 13
ALK Positive, Inc. Sponsors Real-World Registry that Confirms the Success of Modern ALK Therapy, and the Contribution of ALK Positive’s Collaborative Clinical Trial Efforts.2 min read · Aug 17
New Phase 1 Trial Will Explore AQUA07 in ALK-positive NSCLC2 min read · Aug 16
Clinical Trials Update: ALK Research Makes a Big Splash @ The ASCO Conference4 min read · Jul 20
Strawberry Goat Cheese Crostini1 min read · Jul 16
Patient Spotlight: Laura Reed5 min read · Jul 16